Anzeige
Mehr »
Donnerstag, 24.07.2025 - Börsentäglich über 12.000 News
Neubewertung voraus? Wird die Aktivierung der EU-Lizenz zum Kurs-Katalysator für die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
09.07.Update: MSD confirms $10bn takeover deal for Verona Pharma
09.07.Novo Nordisk files high-dose Wegovy in EU
09.07.Is MSD preparing a $10bn deal to buy Verona Pharma?
09.07.New radiopharma Actithera emerges with $75.5m in financing
08.07.Taiho's late-stage Duchenne candidate fails trial
08.07.Boehringer raises hope of oral drug for diabetic eye disease
08.07.First malaria drug for newborns and young infants cleared
08.07.Medical groups sue RFK Jr over COVID-19 policies
08.07.Samsung builds digital health credentials with Xealth buy
07.07.Apogee rises as long-acting eczema drug heads for phase 3
07.07.KalVista bags FDA approval for delayed oral HAE drug
07.07.Charities call for shake-up in UK rare disease R&D
07.07.Trump signs Medicaid-slashing budget into law
07.07.J&J bids to extend prostate cancer uses for Akeega
04.07.UK pharma has concerns about the new NHS 10-year plan
04.07.AZ claims EU okay for Imfinzi in bladder cancer
04.07.Pharma welcomes EU push to restore life sciences sector
03.07.Summit Therapeutics climbs on rumour of $15bn AstraZeneca interest
03.07.NICE relents on Takeda colorectal cancer drug Fruzaqla
03.07.The NHS 10-year plan arrives - what are the highlights?
03.07.Dizal set to bring lung cancer drug Zegfrovy to US
03.07.Novartis drug flunks phase 3 test in giant cell arteritis
03.07.Regeneron gets long-awaited FDA okay for myeloma drug
03.07.UK government reveals neighbourhood healthcare delivery plan
02.07.GlucoModicum's non-invasive CGM nears first filing